Capha Pharmaceuticals Inc.
FPSUF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1 | $1 | $1 | $2 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $1 | $1 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $1 | $1 | $1 | $3 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | -$0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $1 |
| Other Assets | $0 | $0 | $0 | -$0 |
| Total Assets | $2 | $2 | $2 | $3 |
| Liabilities | – | – | – | – |
| Payables | $12 | $0 | $0 | $0 |
| Short-Term Debt | $560 | $489 | $416 | $338 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $12 | -$99 | -$56 |
| Total Curr. Liab. | $572 | $501 | $317 | $282 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $572 | $501 | $317 | $282 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $11,454 | $11,454 | $8,454 | $9,068 |
| Retained Earnings | -$15,716 | -$15,646 | -$11,494 | -$12,269 |
| AOCI | $127 | $127 | $2,724 | $2,922 |
| Other Equity | $3,565 | $3,565 | $0 | $0 |
| Total Equity | -$571 | -$500 | -$316 | -$279 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2 | $2 | $2 | $3 |
| Net Debt | $559 | $488 | $415 | $336 |